London · Main Market · IPO · DOCS
Dr. Martens plc
Dr. Martens plc (DOCS) was admitted to Main Market on Feb 3, 2021, raising £1.29B at 370p per share. Its market capitalization at admission was about £3.7B. Brokers: Goldman Sachs (joint global coordinator), Morgan Stanley (sole sponsor, joint global coordinator), Lazard (financial adviser) and BofA Securities (joint bookrunner).
Dr. Martens is a global footwear brand that has been associated with rebellious self-expression for over 60 years, listing on the Main Market with shares sold by its majority shareholder and other existing holders.
- Type
- IPO
- Market
- Main Market · Premium
- Ticker (TIDM)
- DOCS
- Admitted
- Feb 3, 2021
- Offer price
- 370p
- Raised
- £1.29B
- Market cap at admission
- £3.7B
- Brokers
- Goldman Sachs (joint global coordinator), Morgan Stanley (sole sponsor, joint global coordinator), Lazard (financial adviser), BofA Securities (joint bookrunner) and Barclays (joint bookrunner)
- Sector
- Consumer
- Country
- United Kingdom
More on this listing for subscribers
- Intention-to-float date
- Shares in issue at admission
- Free float
- Source announcements
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Sources
From company announcements filed with the FCA's National Storage Mechanism. Subscribers see the list of announcements for each listing.
Other London listings around the same time
- Cornish Metals Inc.AIM · Feb 16, 2021
- MGC PharmaceuticalsMain Market · Feb 9, 2021
- Foresight Group Holdings LimitedMain Market · Feb 9, 2021
- Moonpig Group plcMain Market · Feb 5, 2021
- VH Global Sustainable Energy Opportunities plcMain Market · Feb 2, 2021
- Supreme plcAIM · Feb 1, 2021